Is DXM legal in Poland?
Also known as: robo, dextromethorphan
- Legal status
- Not named in the Polish national list, and the exclusion is express rather than a silence. The 2025 amending regulation rewrote «LEWOMETORFAN*)» at lp. 115 and «LEWORFANOL*)» at lp. 117 of group I-N and added a footnote row to the table, marked to those two entries, reading «Z wyłączeniem substancji dekstrometorfan» and continuing with the chemical designations of dextromethorphan and dextrorphan. So the annex reaches the levorotatory morphinans and says in terms that it does not reach their dextrorotatory counterparts.
- Consequences if caught
- Capital exposure: none. Poland has no death penalty, and no drug offence attaches to this row at all on the list as read. That makes this a positive statement of absence by the instrument rather than a failure to find an entry, which is a materially stronger finding than an ordinary search returning nothing. Racemethorphan remains listed at lp. 167 of the same group, so a racemic preparation is not covered by the exclusion. Dextromethorphan remains a pharmacy medicine under Polish pharmaceutical law, and that regime was not read in this pass. This absence is stated as at the consolidated text of 17 June 2024, Dz.U. 2024 poz. 1139, as that text stands after the amending regulations of 30 April 2025, Dz.U. 2025 poz. 598, and of 7 July 2026, Dz.U. 2026 poz. 934, read at api.sejm.gov.pl on 21 September 2026. The power to move the list belongs to the Minister of Health, exercised by rozporządzenie under article 44f of the 2005 Act, and that does not rule out a later rozporządzenie made after the date of this reading.
- If prescribed or medical
- Sold as an antitussive under pharmaceutical law rather than as a controlled medicine. No controlled prescription form applies.
- Documentation
- No controlled drug documentation arises under the drug law, because the annex expressly excludes the substance.
- Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, tekst jednolity Dz.U. 2024 poz. 1139
- api.sejm.gov.pl
- Rozporządzenie Ministra Zdrowia z dnia 30 kwietnia 2025 r. zmieniające to rozporządzenie, Dz.U. 2025 poz. 598, w mocy od 22 maja 2025 r.
- api.sejm.gov.pl
- Rozporządzenie Ministra Zdrowia z dnia 7 lipca 2026 r. zmieniające to rozporządzenie, Dz.U. 2026 poz. 934, w mocy od 28 lipca 2026 r.
- api.sejm.gov.pl
- Ustawa z dnia 29 lipca 2005 r. o przeciwdziałaniu narkomanii, tekst jednolity Dz.U. 2023 poz. 1939, art. 4 pkt 25 i 26, art. 31, art. 32, art. 33, art. 44f, art. 62, art. 62a, art. 62b
- api.sejm.gov.pl
- the regulation, both amending regulations and the Act were read at api.sejm.gov.pl on 21 September 2026
Want to know if Poland changes its law on DXM?
Drug-law changes, court decisions and research, once a month.
Free. We email you once to confirm. Unsubscribe with one click.
Court records
We have not yet assessed whether court records are publicly available for this jurisdiction.
DXM in related jurisdictions
Other substances confirmed in Poland
Same substance, other countries
Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Poland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →